SUBSCRIBE
SUBSCRIBE

Earnings

Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
Pfizer Ad Spending Dwarfs Competitors
March 30, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Juno Therapeutics Falls as Company Projects Up to $150 Million Cash Burn in First Post-IPO Earnings Report
March 19, 2015
 · 
5 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Salix Pharmaceuticals, Ltd. Overstated Revenue and Income by Millions: Audit
January 29, 2015
 · 
2 min read
J.P. Morgan: Bluebird Bio Trading Near Historic Highs
Business
J.P. Morgan: Gilead Sciences, Inc. President Says 48% of Revenue Comes From Hep C Drugs
January 13, 2015
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Regeneron’s Earnings Disappoint; Dumps More And More Cash On R&D
November 4, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
Gilead Sciences, Inc. Nervous As Johnson & Johnson Looks To Remain Competitive In Hepatitis C Market
October 15, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Novo Nordisk A/S Leapfrogs GlaxoSmithKline To Take Spot As Europe’s Fourth Largest Drugmaker By Market Value
August 5, 2014
 · 
2 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Business
4 Ways Gilead Sciences, Inc.’s Earnings Will Impact Every American
July 24, 2014
 · 
1 min read
Business
Volcano Corporation Reports 12 Percent Increase in First Quarter Revenues
May 3, 2012
 · 
3 min read
Business
PLC Systems, Inc. Reports Third Quarter 2011 Results
November 14, 2011
 · 
5 min read
Load More
PRESS RELEASES
Press Releases
INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
February 23, 2026
 · 
18 min read
Press Releases
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences
February 23, 2026
 · 
1 min read
Press Releases
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026
 · 
1 min read
Press Releases
UroGen Pharma to Report Fourth Quarter and Full-Year 2025 Financial Results on Monday, March 2, 2026
February 23, 2026
 · 
1 min read
Press Releases
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update
February 23, 2026
 · 
1 min read
Press Releases
ImmunityBio Reports 700% Year-Over-Year Revenue Growth, Expanded ANKTIVA® Approvals in Lung Cancer and Global Commercial Partnerships in 33 Countries with Label Expansion Plans Globally
February 23, 2026
 · 
19 min read
Press Releases
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
February 23, 2026
 · 
18 min read
Press Releases
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026
February 23, 2026
 · 
1 min read
Press Releases
Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 23, 2026
 · 
17 min read
Press Releases
Almirall’s 2025 Results
February 23, 2026
 · 
9 min read
Press Releases
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
February 22, 2026
 · 
17 min read
Press Releases
Abbott declares 409th consecutive quarterly dividend
February 22, 2026
 · 
1 min read
Press Releases
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
February 20, 2026
 · 
1 min read
Press Releases
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
February 20, 2026
 · 
3 min read
Press Releases
Cantargia Publishes Full Year Report 2025
February 20, 2026
 · 
3 min read
Press Releases
Annual report 2025: ALK delivers 15% revenue growth and 26% EBIT margin
February 20, 2026
 · 
4 min read
Press Releases
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
February 19, 2026
 · 
16 min read
Press Releases
Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights
February 19, 2026
 · 
16 min read
Press Releases
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance
February 19, 2026
 · 
19 min read
Press Releases
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
February 19, 2026
 · 
13 min read
Load More